Soleus Capital Management, L.P.
Filing Date
Global Rank
#1,069
/ 8,700
▲ 216
Top Industry
Biotechnology
60.4%
Period ended 2 months ago
Filed Aug 11, 2026 · 33d
26 quarters · since Mar 2020
Portfolio Concentration
97 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
12.0%
−0.0 pts
Top 5
34.4%
+1.6 pts
Top 10
48.9%
−1.4 pts
HHI
371
Diversified−10
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,901,982,840 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | +1,833,504 | 1,843,504 | $72,117,876 | |
| INSP | Inspire Medical Systems, Inc. | +1,355,137 | 1,931,436 | $86,161,359 | |
| GERN | Geron Corp | +1,300,000 | 42,808,659 | $54,795,083 | |
| AVTX | Avalo Therapeutics, Inc. | +1,213,000 | 1,654,978 | $30,583,993 | |
| PRCT | PROCEPT BioRobotics Corp | +843,000 | 1,003,000 | $22,647,740 | |
| JBIO | Jade Biosciences, Inc. | +753,946 | 1,550,690 | $34,456,331 | |
| RCUS | Arcus Biosciences, Inc. | +716,755 | 1,168,738 | $36,032,192 | |
| NRIX | Nurix Therapeutics, Inc. | +527,000 | 1,465,163 | $35,544,854 | |
| PODD | Insulet Corp | +486,500 | 1,049,000 | $159,710,250 | |
| CELC | Celcuity Inc. | +419,940 | 1,704,318 | $178,305,749 | |
| MBX | MBX Biosciences, Inc. | +336,382 | 515,279 | $28,443,400 | |
| TNGX | Tango Therapeutics, Inc. | +259,000 | 709,000 | $22,163,340 | |
| BDSX | Biodesix Inc | +169,359 | 585,958 | $13,213,352 | |
| KIDS | Orthopediatrics Corp | +116,697 | 732,144 | $14,005,914 | |
| URGN | UroGen Pharma Ltd. | +102,810 | 829,810 | $30,537,008 | |
| CNTX | Context Therapeutics Inc. | +100,000 | 7,063,141 | $3,912,980 | |
| INSM | INSMED Inc | +80,000 | 90,250 | $9,622,455 | |
| ORGO | Organogenesis Holdings Inc. | +55,000 | 10,140,951 | $24,642,510 | |
| ANIP | Ani Pharmaceuticals Inc | +47,517 | 867,760 | $71,833,172 | |
| BBNX | Beta Bionics, Inc. | +39,213 | 4,393,714 | $68,849,498 | |
| UTHR | UNITED THERAPEUTICS Corp | +38,400 | 225,587 | $122,229,804 | |
| PHVS | Pharvaris N.V. | +28,855 | 730,907 | $25,274,764 | |
| GPCR | Structure Therapeutics Inc. | +27,000 | 107,000 | $5,742,690 | |
| IMVT | Immunovant, Inc. | +22,000 | 252,000 | $9,709,560 | |
| ARGX | Argenx SE | +16,455 | 19,955 | $18,513,650 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CERS | Cerus Corp | −8,253,700 | 2,500,000 | $7,300,000 | |
| IMUX | Immunic, Inc. | −4,050,000 | 450,000 | $6,916,500 | |
| EOLS | Evolus, Inc. | −1,422,932 | 822,428 | $5,707,650 | |
| TWST | Twist Bioscience Corp | −1,122,000 | 104,629 | $10,764,231 | |
| TGTX | Tg Therapeutics, Inc. | −1,101,424 | 2,927,895 | $160,858,551 | |
| VCEL | Vericel Corp | −1,089,927 | 1,459,152 | $64,917,672 | |
| VIR | Vir Biotechnology, Inc. | −1,002,000 | 1,000,000 | $10,190,000 | |
| EWTX | Edgewise Therapeutics, Inc. | −999,026 | 450,889 | $18,319,620 | |
| ALKS | Alkermes plc. | −941,612 | 1,029,252 | $53,932,804 | |
| LRMR | Larimar Therapeutics, Inc. | −878,858 | 188,102 | $573,711 | |
| IOVA | Iovance Biotherapeutics, Inc. | −850,000 | 150,000 | $624,000 | |
| AXGN | Axogen, Inc. | −622,134 | 57,036 | $2,634,492 | |
| NVCR | NovoCure Ltd | −578,990 | 9,913,401 | $150,188,025 | |
| PGNY | Progyny, Inc. | −465,000 | 1,602,000 | $46,185,660 | |
| TRVI | Trevi Therapeutics, Inc. | −440,382 | 1,179,618 | $21,999,875 | |
| CCCC | C4 Therapeutics, Inc. | −425,961 | 3,377,981 | $15,775,171 | |
| CGEM | Cullinan Therapeutics, Inc. | −360,200 | 50,000 | $910,500 | |
| LIVN | LivaNova PLC | −327,543 | 254,957 | $20,965,114 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −325,306 | 75,000 | $8,780,250 | |
| VCYT | Veracyte, Inc. | −294,912 | 25,000 | $1,468,250 | |
| SOPH | SOPHiA GENETICS SA | −285,000 | 1,565,000 | $9,030,050 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | −275,000 | 246,353 | $15,754,274 | |
| BMRN | Biomarin Pharmaceutical Inc | −275,000 | 375,572 | $21,490,229 | |
| CORT | Corcept Therapeutics Inc | −265,878 | 19,653 | $1,708,828 | |
| GMED | Globus Medical Inc | −260,545 | 468,922 | $37,049,527 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
21 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ERAS | Erasca, Inc. | 2,700,000 | $49,464,000 | |
| PBLS | Parabilis Medicines, Inc. | 1,465,070 | $40,098,965 | |
| LEGN | Legend Biotech Corp | 1,205,000 | $34,800,400 | |
| UNH | Unitedhealth Group Inc | 80,000 | $33,250,400 | |
| PALI | Palisade Bio, Inc. | 13,063,687 | $27,303,105 | |
| SUPN | Supernus Pharmaceuticals, Inc. | 520,000 | $24,185,200 | |
| NVCT | Nuvectis Pharma, Inc. | 1,000,000 | $18,390,000 | |
| CAPR | Capricor Therapeutics, Inc. | 761,737 | $18,342,626 | |
| PRLD | Prelude Therapeutics Inc | 3,378,378 | $18,006,754 | |
| AVLN | Avalyn Pharma Inc. | 419,000 | $13,793,480 | |
| SYRE | Spyre Therapeutics, Inc. | 147,000 | $13,050,660 | |
| NKTR | Nektar Therapeutics | 128,362 | $8,960,951 | |
| AORT | Artivion, Inc. | 388,000 | $8,718,360 | |
| BLTE | Belite Bio, Inc | 50,524 | $7,779,938 | |
| SLN | Silence Therapeutics plc | 630,000 | $6,917,400 | |
| ANL | Adlai Nortye Group Ltd. | 405,523 | $4,663,514 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 950,000 | $4,607,500 | |
| AVBP | ArriVent BioPharma, Inc. | 50,000 | $1,737,000 | |
| SLDB | Solid Biosciences Inc. | 150,000 | $1,498,500 | |
| WGS | GeneDx Holdings Corp. | 10,000 | $686,500 | |
| EQ | Equillium, Inc. | 90,000 | $288,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 385,472 | $22,399,777 | |
| ICLR | Icon PLC | 192,000 | $21,246,720 | |
| TVTX | Travere Therapeutics, Inc. | 546,000 | $16,221,660 | |
| INBX | Inhibrx Biosciences, Inc. | 131,000 | $8,807,130 | |
| DXCM | Dexcom Inc | 140,000 | $8,792,000 | |
| ETON | Eton Pharmaceuticals, Inc. | 166,381 | $4,106,283 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 28,479 | $1,785,633 | |
| CTMX | CytomX Therapeutics, Inc. | 300,000 | $1,410,000 | |
| COGT | Cogent Biosciences, Inc. | 10,000 | $384,900 | |
| TYRA | Tyra Biosciences, Inc. | 10,000 | $383,000 | |
| STAA | Staar Surgical Co | 20,000 | $374,000 | |
| ANAB | Anaptysbio, Inc | 6,000 | $332,759 | |
| RAPP | Rapport Therapeutics, Inc. | 10,000 | $312,900 | |
| ZYME | Zymeworks Inc. | 10,000 | $250,400 | |
| LBRX | Lb Pharmaceuticals Inc | 10,000 | $246,600 | |
| ORKA | Oruka Therapeutics, Inc. | 5,000 | $245,250 | |
| JSPR | Jasper Therapeutics, Inc. | 276,312 | $242,049 | |
| No positions match the current search. | ||||
97 tracked positions ·
$2,901,982,840 total
· filing declares
97 positions · $2,901,979,696
· as of Jun 30, 2026
Showing 1–50
of 97 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 939,254 | $349,092,534 | 12.03% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 1,704,318 | $178,305,749 | 6.14% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 2,927,895 | $160,858,551 | 5.54% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 1,049,000 | $159,710,250 | 5.50% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Reduced | 9,913,401 | $150,188,025 | 5.18% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 225,587 | $122,229,804 | 4.21% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Added | 1,931,436 | $86,161,359 | 2.97% | |
| RIGL |
Rigel Pharmaceuticals Inc
Healthcare
|
Added | 1,843,504 | $72,117,876 | 2.49% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 867,760 | $71,833,172 | 2.48% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 4,393,714 | $68,849,498 | 2.37% | |
| VCEL |
Vericel Corp
Healthcare
|
Reduced | 1,459,152 | $64,917,672 | 2.24% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 177,517 | $59,430,916 | 2.05% | |
| GERN |
Geron Corp
Healthcare
|
Added | 42,808,659 | $54,795,083 | 1.89% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 1,029,252 | $53,932,804 | 1.86% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 2,700,000 | $49,464,000 | 1.70% | |
| NPCE |
NeuroPace Inc
Healthcare
|
Reduced | 2,911,122 | $46,257,728 | 1.59% | |
| PGNY |
Progyny, Inc.
Healthcare
|
Reduced | 1,602,000 | $46,185,660 | 1.59% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,064,000 | $43,655,920 | 1.50% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
NEW | 1,465,070 | $40,098,965 | 1.38% | |
| FOCL |
Edap Tms SA
Healthcare
|
Held | 7,309,254 | $37,861,935 | 1.30% | |
| GMED |
Globus Medical Inc
Healthcare
|
Reduced | 468,922 | $37,049,527 | 1.28% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 1,168,738 | $36,032,192 | 1.24% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 1,628,039 | $35,588,932 | 1.23% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 1,465,163 | $35,544,854 | 1.22% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
NEW | 1,205,000 | $34,800,400 | 1.20% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 1,550,690 | $34,456,331 | 1.19% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 80,000 | $33,250,400 | 1.15% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 1,654,978 | $30,583,993 | 1.05% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 829,810 | $30,537,008 | 1.05% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 515,279 | $28,443,400 | 0.98% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
NEW | 13,063,687 | $27,303,105 | 0.94% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 730,907 | $25,274,764 | 0.87% | |
| ORGO |
Organogenesis Holdings Inc.
Healthcare
|
Added | 10,140,951 | $24,642,510 | 0.85% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
NEW | 520,000 | $24,185,200 | 0.83% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Added | 1,003,000 | $22,647,740 | 0.78% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 709,000 | $22,163,340 | 0.76% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 10,875,000 | $22,076,250 | 0.76% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 1,179,618 | $21,999,875 | 0.76% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 375,572 | $21,490,229 | 0.74% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 254,957 | $20,965,114 | 0.72% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 19,955 | $18,513,650 | 0.64% | |
| NVCT |
Nuvectis Pharma, Inc.
Healthcare
|
NEW | 1,000,000 | $18,390,000 | 0.63% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
NEW | 761,737 | $18,342,626 | 0.63% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 450,889 | $18,319,620 | 0.63% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
NEW | 3,378,378 | $18,006,754 | 0.62% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 267,000 | $16,116,120 | 0.56% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
Reduced | 3,377,981 | $15,775,171 | 0.54% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 246,353 | $15,754,274 | 0.54% | |
| KIDS |
Orthopediatrics Corp
Healthcare
|
Added | 732,144 | $14,005,914 | 0.48% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 419,000 | $13,793,480 | 0.48% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.